Yamada, Gotaro <br/><br/>
Virological response in patients with hepatitis C virus genotype 1b and a high viral load: impact of peginterferon-alpha-2a plus ribavirin dose reductions and host-related factors.  [electronic resource] 

 -  Clinical drug investigation  2008 
 - 9-16 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1173-2563 
<br/><br/><label>Standard No.: </label>10.2165/00044011-200828010-00002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antiviral Agents--administration & dosage<br/>Clinical Trials, Phase III as Topic<br/>Databases, Factual<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>Hepacivirus--drug effects<br/>Hepatitis C--blood<br/>Host-Pathogen Interactions<br/>Humans<br/>Injections, Subcutaneous<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Japan<br/>Male<br/>Middle Aged<br/>Polyethylene Glycols--administration & dosage<br/>RNA, Viral--blood<br/>Randomized Controlled Trials as Topic<br/>Recombinant Proteins<br/>Retrospective Studies<br/>Ribavirin--administration & dosage<br/>Time Factors<br/>Treatment Outcome<br/>Viral Load